Liver Transplantation Market
Liver Transplantation emerging as an important procedure to treat diseases such as Hepatitis A, B & C
Liver Transplantation Market by Treatment, End Use & region - Forecast 2022 - 2032
Liver Transplantation Market Outlook (2022-2032)
[298 Pages Report] The global liver transplantation market is expected to secure US$ 2,539.61 Million in 2032 while expanding at a CAGR of 6.6%. A future that will be a success for liver transplantation is in line with technological advancements and split liver transplantation, in which a single liver is used for two recipients. In the future, these factors will further contribute to the growth of the liver transplantation market. The market is likely to hold a value of US$ 1,340.28 Million in 2022. From 2016-21, the market displayed a growth rate of 6.5%.
|
Data Points |
Key Statistics |
|
Expected Base Year Value (2022) |
US$ 1,340.28 Million |
|
Anticipated Forecast Value (2032) |
US$ 2,539.61 Million |
|
Estimated Growth (2022-2032) |
6.6% CAGR |
A liver transplant, also known as a hepatic transplant, is a surgical procedure that is performed when a patient's liver is not capable of performing basic functions, such as synthesizing proteins, carbohydrates, and fats. After the kidney, the liver is the second most frequently transplanted major organ, indicating the seriousness of the liver disease. Despite the fact that the majority of liver transplant operations use livers from deceased donors, it is still possible to obtain a liver from a living person as well (allograft). Current liver transplant demand is substantial, however only critically ill patients are considered for transplants, and these patients are selected based on their critical condition.
Approximately 11,000 people were waiting for liver transplants in 2021. In 2021, a total of 9,236 liver transplants were conducted, of which 8,667 were derived from deceased donors and 569 were performed from living donors. As the demand for liver transplants has increased and mortality on the liver transplant waitlist has been unacceptably high, there has been growing interest in strategies to alleviate these problems. The use of LDLT can be considered as one such approach, as it can increase the number of grafts that can be transplanted. In spite of this, it is important for donors and recipients to maintain both short-term and long-term outcomes in the long run. As a result, it was imperative to compare the characteristics of donors and recipients and the post-transplant outcomes after LDLT in order to draw some conclusions.
Let us know your requirement to get
100% FREE customization
What Factors are Driving Growth of the Liver Transplantation Market?
As hepatitis A, B, and C incidence increases worldwide, the liver transplantation market is expected to grow in the coming years. A major driving force in the liver transplantation market is the advancement of treatment and the increase in adoption as the most effective method of managing end-stage liver disease.
Additionally, reimbursement policies are likely to become increasingly favorable in the near future, leading to a growth in liver transplantation. The fact that organ transplantation is becoming an increasingly popular treatment for organ failure is one of the most significant factors contributing to the growth of the market.
During the coming years, the market will experience a great deal of growth due to the rise of passive lifestyles, bad eating habits, excessive drinking, and drug abuse being among the main factors that are driving the market to grow. Various causes of liver failure among the global population as well as the growing geriatric population have increased the demand for liver transplants in various regions.
Restricting Factors for the Global Liver Transplantation Market?
There are several risks associated with this procedure, including severe bleeding and negative reactions that can be life-threatening, which is a restraint on its use. Several other diseases that can occur as a result of transplants, such as diabetes, high cholesterol, and diarrhea, may impact the market's growth. Staying in a hospital for a long period of time can be expensive, which can hamper the growth of the liver transplantation market.
In addition, there are several factors that contributed to the sharp decline in the market's revenue not only in recent years, but also in the future, including the shortage of primary intensive care units, protective equipment, and blood products during transplantation. Over the forecast period, however, liver transplantation market growth can be hindered by a shortage of liver donors, increased waiting lists for liver transplants, and an increase in hospitalization time and costs. As a result, liver transplantation will see a decline in market share in the near future.
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystWhy is North America the Leading Market for Liver Transplants?
According to the forecast, North America will continue to have a high demand for liver transplantation in the market. Globally, this region is projected to hold 29% of the market share by 2022. The expansion of infrastructure and the use of advanced equipment in this region has greatly contributed to a rise in the demand for liver transplantation in this region.
As awareness of liver transplantation programs grows and the level of public and private investments in research and development increases, it has contributed to the increase in the market for liver transplantation. A well-developed medical infrastructure and the presence of many large companies in this region have also contributed to liver transplantation's growth.
NewYork-Presbyterian's Living Donor Liver Transplant Program (LDLT) is one of the most experienced and largest programs in the world, offering laparoscopic donor surgeries for most donors in North America. It is estimated that one in five recipients of liver transplants receive a liver from a living donor in this region.
What makes Europe a Promising Market for Liver Transplantation?
Europe is expected to be the second largest region for liver transplantation. A market share of 20% is expected for liver transplants in Europe by 2022. This region is expected to be the fastest growing market in the liver transplantation market over the next five years owing to the rise in the number of surgical procedures in the region. A rise in the number of R&D activities initiated by the government in this region as well as an escalating number of chronic diseases in this region is expected to increase liver transplantation market demand.
European liver transplants have become a life-saving treatment for patients with chronic liver diseases, hepatocellular carcinoma, and acute liver disorders. There are many transnational organizations in Europe, such as Eurotransplant and Scandiatransplant, which cooperate among European countries. The European Liver Transplant Registry (ELTR) represents over 98% of European liver transplant data from 153 centers. Europeans perform nearly 6,000 liver transplants annually. Considering all the factors above, liver transplantation in this area has been on the rise.
A unified Market Research Subscription Platform, built for today's disparate research needs.
Category-wise Insights
What is the Growth Rate of Liver Transplantation Surgeries in the Healthcare Industry?
Based on treatment type, the market for liver transplantation surgery is expected to show an above-average CAGR of 5% over the forecast period. Modern living-related liver transplant techniques and evolving surgical techniques have led to an increase in liver transplant surgery demand. Throughout the world, the prevalence of chronic diseases as well as the high consumption of alcohol have contributed to an increase in the number of liver transplantation surgeries being carried out in the medical sector.
American Liver Foundation statistics indicate that around 8,000 liver transplants are performed annually. The growing cost of these surgeries will, however, hamper the growth of the liver translation market in the near future. Additionally, advanced medical equipment, medical products, and trained medical personnel have all contributed to the growth of the liver transplantation surgery market.
Also, the positive statistics for these surgeries are growing in various regions, which will further increase their demand. A well-equipped and advanced liver transplant center in India, however, has a success rate of more than 95%. According to the report, 95 out of 100 liver transplant patients were discharged in good health. Moreover, the transplant has a high long-term success rate, contributing to its popularity in the market.
Why Hospitals are in Great Demand for Liver Transplantation?
Based on end-use, the market is segmented into hospitals, ambulatory surgical centers, and adult liver transplantation centers. According to the forecast, hospitals will account for about 50% of global liver transplantation market revenue by 2026. Various new technologies and innovations in the hospital are expected to enhance the treatment of patients suffering from end-stage liver diseases in the hospital.
The market for liver transplantation is expected to grow in hospitals where excellent clinical outcomes and successful surgeries are performed by specialists that contribute to the growth of the market. Most hospitals have access to online databases that permit them to check for organ availability ensuring quick medical intervention during an emergency. Additionally, rising government interventions to encourage organ donation are likely to drive the hospital liver transplant market growth.
How do Healthcare Start-ups Affect the Liver Transplant Industry?
Many start-ups are coming up with new technologies that might help identify areas for improvement in healthcare and clarify if it would be worthwhile to expand LDLT practices in countries that rely primarily on DDLT. Apart from liver transplants, these healthcare startups conduct a wide range of research and clinical trials. It has been observed that most start-up companies have focused primarily on improving technologies and devices for treating liver diseases.
- Vital Therapies, was founded in 2003 in San Diego, United States. Cell-based therapy is being developed by Vital Therapies for the treatment of acute liver failure. With the ELAD System, the company's lead product, patients can restore their liver to a healthy state or stabilize themselves until liver transplantation can take place. Acute liver failure is a condition for which ELAD has been designated an orphan drug in both European and American markets.
- HepaTx, was founded in 2015 in Palo, United States. HepaTx develops therapies to treat liver disease using regenerative medicine. Based on Stanford's platform technology, they can efficiently develop therapeutic hepatocytes. They're looking at ways to restore liver function to patients who would normally require liver transplants due to end-stage liver disease.
- Humedics was founded in 2009, in Berlin, Germany. Point-of-care breath-based liver function tests are developed by the company. CYP1A2, which is part of the P450 family, is present in higher concentrations in liver tissue, and the company's flagship product LiMax measures its activity. Radioactively labeled C13 methacetin is given to the subject. C-13 and paracetamol, along with C-13, are used in the assay to produce carbon dioxide in CYP1A2. By measuring C-13 levels in exhaled breath along with liver capacity, the LiMax test mask can detect liver disease at an early stage. Hepatology, oncology, and liver surgery are some of the applications.
Competition Analysis
Key players in the global liver transplantation market include Allosource, Conatus Pharmaceuticals Inc., Digna Biotech, S.L., Dompe Farmaceutici S.p.A., Isogenis, Inc., RedHill Biopharma Ltd., Thompson Surgical, Integra Life Sciences, Baxter International Inc., XVIVO, VirTech Bio, Vital Therapies, HepaTx, Humedics and others.
- In September 2022, XVIVO received Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA) for its Liver Assist device, which is intended to preserve donor livers before transplantation using oxygenated machine perfusion. Through the FDA's Breakthrough Device Program, certain medical devices will be developed and reviewed more quickly and more efficiently than previous therapies to treat or diagnose diseases that are life-threatening or irreversible.
- In September 2022, the Transplant Authority of Tamil Nadu gave Rela Hospital the award of appreciation for liver transplants for 2021-2022 in three categories. The chairman of the hospital, Mohamed Rela, and his team were awarded an appreciation award for performing the most pediatric liver transplants under the Chief Minister's Comprehensive Health Insurance Scheme (CMCHIS) and liver transplantation in the state during 2021-2022. More than 100 children from the State have received liver transplants at the hospital supported by CMCHIS.
Report Scope
|
Report Attribute |
Details |
|
Growth Rate |
CAGR of 6.6% from 2022-2032 |
|
Market Value in 2022 |
US$ 1,340.28 Million |
|
Market Value in 2032 |
US$ 2,539.61 Million |
|
Base Year for Estimation |
2021 |
|
Historical Data |
2016-2021 |
|
Forecast Period |
2022-2032 |
|
Quantitative Units |
Revenue in US$ Million and CAGR from 2022-2032 |
|
Report Coverage |
Revenue Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends, and Pricing Analysis |
|
Segments Covered |
|
|
Regions Covered |
|
|
Key Countries Profiled |
|
|
Key Companies Profiled |
|
|
Customization |
Available Upon Request |
Key Segments Profiled in the Global Liver Transplantation Market
Liver Transplantation Market by Treatment Type:
- Liver Transplantation Surgery
- Post-Surgery Anti-Rejection Treatment
- Cyclosporine
- Tacrolimus
- Sirolimus
- Prednisone
- Azathioprine
- Mycophenolate Mofetil
Liver Transplantation Market by End Use:
- Liver Transplantation in Hospitals
- Liver Transplantation in Adult Liver Transplantation Centers
- Liver Transplantation in Ambulatory Surgical Centers
Liver Transplantation Market by Region:
- North America Liver Transplantation Market
- Latin America Liver Transplantation Market
- Europe Liver Transplantation Market
- East Asia Liver Transplantation Market
- South Asia Liver Transplantation Market
- Oceania Liver Transplantation Market
- Middle East & Africa Liver Transplantation Market
Frequently Asked Questions
FMI projects the global liver transplantation market to expand at a 6.6% value CAGR by 2032
North America is expected to be the most opportunistic liver transplantation market, accumulating 29% revenue in 2022
Allosource, Conatus Pharmaceuticals Inc., Digna Biotech, S.L., Dompe Farmaceutici S.p.A., and Isogenis, Inc. are some of the prominent players in the market.
Table of Content
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Investment Feasibility Matrix
3.5. PESTLE and Porter’s Analysis
3.6. Regulatory Landscape
3.6.1. By Key Regions
3.6.2. By Key Countries
3.7. Regional Parent Market Outlook
4. Global Liver Transplantation Market Analysis 2016-2021 and Forecast, 2022-2032
4.1. Historical Market Size Value (US$ Mn) Analysis, 2016-2021
4.2. Current and Future Market Size Value (US$ Mn) Projections, 2022-2032
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Liver Transplantation Market Analysis 2016-2021 and Forecast 2022-2032, By Treatment Type
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Mn) Analysis By Treatment type, 2016-2021
5.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Treatment type, 2022-2032
5.3.1. Liver Transplantation Surgery
5.3.2. Post-Surgery Anti-Rejection Treatment Liver Transplantation
5.3.3. Cyclosporine in Liver Transplantation
5.3.4. Tacrolimus in Liver Transplantation
5.3.5. Sirolimus in Liver Transplantation
5.3.6. Prednisone in Liver Transplantation
5.3.7. Azathioprine in Liver Transplantation
5.3.8. Mycophenolate Mofetil in Liver Transplantation
5.4. Y-o-Y Growth Trend Analysis By Treatment type, 2016-2021
5.5. Absolute $ Opportunity Analysis By Treatment type, 2022-2032
6. Global Liver Transplantation Market Analysis 2016-2021 and Forecast 2022-2032, By End use
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Mn) Analysis By End use, 2016-2021
6.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By End use, 2022-2032
6.3.1. Liver Transplantation at Hospitals
6.3.2. Liver Transplantation in Adult Liver Transplantation Centers
6.3.3. Liver Transplantation in Ambulatory Surgical Centers
6.4. Y-o-Y Growth Trend Analysis By End use, 2016-2021
6.5. Absolute $ Opportunity Analysis By End use, 2022-2032
7. Global Liver Transplantation Market Analysis 2016-2021 and Forecast 2022-2032, By Region
7.1. Introduction
7.2. Historical Market Size Value (US$ Mn) Analysis By Region, 2016-2021
7.3. Current Market Size Value (US$ Mn) Analysis and Forecast By Region, 2022-2032
7.3.1. North America
7.3.2. Latin America
7.3.3. Europe
7.3.4. South Asia
7.3.5. East Asia
7.3.6. Oceania
7.3.7. MEA
7.4. Market Attractiveness Analysis By Region
8. North America Liver Transplantation Market Analysis 2016-2021 and Forecast 2022-2032, By Country
8.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2021
8.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
8.2.1. By Country
8.2.1.1. U.S.
8.2.1.2. Canada
8.2.2. By Treatment type
8.2.3. By End use
8.3. Market Attractiveness Analysis
8.3.1. By Country
8.3.2. By Treatment type
8.3.3. By End use
8.4. Key Takeaways
9. Latin America Liver Transplantation Market Analysis 2016-2021 and Forecast 2022-2032, By Country
9.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2021
9.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
9.2.1. By Country
9.2.1.1. Brazil
9.2.1.2. Mexico
9.2.1.3. Rest of Latin America
9.2.2. By Treatment type
9.2.3. By End use
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Treatment type
9.3.3. By End use
9.4. Key Takeaways
10. Europe Liver Transplantation Market Analysis 2016-2021 and Forecast 2022-2032, By Country
10.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2021
10.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
10.2.1. By Country
10.2.1.1. Germany
10.2.1.2. U.K.
10.2.1.3. France
10.2.1.4. Spain
10.2.1.5. Italy
10.2.1.6. Rest of Europe
10.2.2. By Treatment type
10.2.3. By End use
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Treatment type
10.3.3. By End use
10.4. Key Takeaways
11. South Asia Liver Transplantation Market Analysis 2016-2021 and Forecast 2022-2032, By Country
11.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2021
11.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
11.2.1. By Country
11.2.1.1. India
11.2.1.2. Malaysia
11.2.1.3. Singapore
11.2.1.4. Thailand
11.2.1.5. Rest of South Asia
11.2.2. By Treatment type
11.2.3. By End use
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Treatment type
11.3.3. By End use
11.4. Key Takeaways
12. East Asia Liver Transplantation Market Analysis 2016-2021 and Forecast 2022-2032, By Country
12.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2021
12.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
12.2.1. By Country
12.2.1.1. China
12.2.1.2. Japan
12.2.1.3. South Korea
12.2.2. By Treatment type
12.2.3. By End use
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Treatment type
12.3.3. By End use
12.4. Key Takeaways
13. Oceania Liver Transplantation Market Analysis 2016-2021 and Forecast 2022-2032, By Country
13.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2021
13.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
13.2.1. By Country
13.2.1.1. Australia
13.2.1.2. New Zealand
13.2.2. By Treatment type
13.2.3. By End use
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Treatment type
13.3.3. By End use
13.4. Key Takeaways
14. MEA Liver Transplantation Market Analysis 2016-2021 and Forecast 2022-2032, By Country
14.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2021
14.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
14.2.1. By Country
14.2.1.1. GCC Countries
14.2.1.2. South Africa
14.2.1.3. Israel
14.2.1.4. Rest of MEA
14.2.2. By Treatment type
14.2.3. By End use
14.3. Market Attractiveness Analysis
14.3.1. By Country
14.3.2. By Treatment type
14.3.3. By End use
14.4. Key Takeaways
15. Key Countries Liver Transplantation Market Analysis
15.1. U.S.
15.1.1. Pricing Analysis
15.1.2. Market Share Analysis, 2021
15.1.2.1. By Treatment type
15.1.2.2. By End use
15.2. Canada
15.2.1. Pricing Analysis
15.2.2. Market Share Analysis, 2021
15.2.2.1. By Treatment type
15.2.2.2. By End use
15.3. Brazil
15.3.1. Pricing Analysis
15.3.2. Market Share Analysis, 2021
15.3.2.1. By Treatment type
15.3.2.2. By End use
15.4. Mexico
15.4.1. Pricing Analysis
15.4.2. Market Share Analysis, 2021
15.4.2.1. By Treatment type
15.4.2.2. By End use
15.5. Germany
15.5.1. Pricing Analysis
15.5.2. Market Share Analysis, 2021
15.5.2.1. By Treatment type
15.5.2.2. By End use
15.6. U.K.
15.6.1. Pricing Analysis
15.6.2. Market Share Analysis, 2021
15.6.2.1. By Treatment type
15.6.2.2. By End use
15.7. France
15.7.1. Pricing Analysis
15.7.2. Market Share Analysis, 2021
15.7.2.1. By Treatment type
15.7.2.2. By End use
15.8. Spain
15.8.1. Pricing Analysis
15.8.2. Market Share Analysis, 2021
15.8.2.1. By Treatment type
15.8.2.2. By End use
15.9. Italy
15.9.1. Pricing Analysis
15.9.2. Market Share Analysis, 2021
15.9.2.1. By Treatment type
15.9.2.2. By End use
15.10. India
15.10.1. Pricing Analysis
15.10.2. Market Share Analysis, 2021
15.10.2.1. By Treatment type
15.10.2.2. By End use
15.11. Malaysia
15.11.1. Pricing Analysis
15.11.2. Market Share Analysis, 2021
15.11.2.1. By Treatment type
15.11.2.2. By End use
15.12. Singapore
15.12.1. Pricing Analysis
15.12.2. Market Share Analysis, 2021
15.12.2.1. By Treatment type
15.12.2.2. By End use
15.13. Thailand
15.13.1. Pricing Analysis
15.13.2. Market Share Analysis, 2021
15.13.2.1. By Treatment type
15.13.2.2. By End use
15.14. China
15.14.1. Pricing Analysis
15.14.2. Market Share Analysis, 2021
15.14.2.1. By Treatment type
15.14.2.2. By End use
15.15. Japan
15.15.1. Pricing Analysis
15.15.2. Market Share Analysis, 2021
15.15.2.1. By Treatment type
15.15.2.2. By End use
15.16. South Korea
15.16.1. Pricing Analysis
15.16.2. Market Share Analysis, 2021
15.16.2.1. By Treatment type
15.16.2.2. By End use
15.17. Australia
15.17.1. Pricing Analysis
15.17.2. Market Share Analysis, 2021
15.17.2.1. By Treatment type
15.17.2.2. By End use
15.18. New Zealand
15.18.1. Pricing Analysis
15.18.2. Market Share Analysis, 2021
15.18.2.1. By Treatment type
15.18.2.2. By End use
15.19. GCC Countries
15.19.1. Pricing Analysis
15.19.2. Market Share Analysis, 2021
15.19.2.1. By Treatment type
15.19.2.2. By End use
15.20. South Africa
15.20.1. Pricing Analysis
15.20.2. Market Share Analysis, 2021
15.20.2.1. By Treatment type
15.20.2.2. By End use
15.21. Israel
15.21.1. Pricing Analysis
15.21.2. Market Share Analysis, 2021
15.21.2.1. By Treatment type
15.21.2.2. By End use
16. Market Structure Analysis
16.1. Competition Dashboard
16.2. Competition Benchmarking
16.3. Market Share Analysis of Top Players
16.3.1. By Regional
16.3.2. By Treatment type
16.3.3. By End use
17. Competition Analysis
17.1. Competition Deep Dive
17.1.1. Allosource
17.1.1.1. Overview
17.1.1.2. Product Portfolio
17.1.1.3. Profitability by Market Segments
17.1.1.4. Sales Footprint
17.1.1.5. Strategy Overview
17.1.1.5.1. Marketing Strategy
17.1.2. Conatus Pharmaceuticals Inc.
17.1.2.1. Overview
17.1.2.2. Product Portfolio
17.1.2.3. Profitability by Market Segments
17.1.2.4. Sales Footprint
17.1.2.5. Strategy Overview
17.1.2.5.1. Marketing Strategy
17.1.3. Digna Biotech
17.1.3.1. Overview
17.1.3.2. Product Portfolio
17.1.3.3. Profitability by Market Segments
17.1.3.4. Sales Footprint
17.1.3.5. Strategy Overview
17.1.3.5.1. Marketing Strategy
17.1.4. S.L.
17.1.4.1. Overview
17.1.4.2. Product Portfolio
17.1.4.3. Profitability by Market Segments
17.1.4.4. Sales Footprint
17.1.4.5. Strategy Overview
17.1.4.5.1. Marketing Strategy
17.1.5. Dompe Farmaceutici S.p.A.
17.1.5.1. Overview
17.1.5.2. Product Portfolio
17.1.5.3. Profitability by Market Segments
17.1.5.4. Sales Footprint
17.1.5.5. Strategy Overview
17.1.5.5.1. Marketing Strategy
17.1.6. Isogenis, Inc.
17.1.6.1. Overview
17.1.6.2. Product Portfolio
17.1.6.3. Profitability by Market Segments
17.1.6.4. Sales Footprint
17.1.6.5. Strategy Overview
17.1.6.5.1. Marketing Strategy
17.1.7. RedHill Biopharma Ltd.
17.1.7.1. Overview
17.1.7.2. Product Portfolio
17.1.7.3. Profitability by Market Segments
17.1.7.4. Sales Footprint
17.1.7.5. Strategy Overview
17.1.7.5.1. Marketing Strategy
17.1.8. Thompson Surgical
17.1.8.1. Overview
17.1.8.2. Product Portfolio
17.1.8.3. Profitability by Market Segments
17.1.8.4. Sales Footprint
17.1.8.5. Strategy Overview
17.1.8.5.1. Marketing Strategy
17.1.9. Integra Life sciences
17.1.9.1. Overview
17.1.9.2. Product Portfolio
17.1.9.3. Profitability by Market Segments
17.1.9.4. Sales Footprint
17.1.9.5. Strategy Overview
17.1.9.5.1. Marketing Strategy
17.1.10. Baxter International Inc.
17.1.10.1. Overview
17.1.10.2. Product Portfolio
17.1.10.3. Profitability by Market Segments
17.1.10.4. Sales Footprint
17.1.10.5. Strategy Overview
17.1.10.5.1. Marketing Strategy
17.1.11. XVIVO
17.1.11.1. Overview
17.1.11.2. Product Portfolio
17.1.11.3. Profitability by Market Segments
17.1.11.4. Sales Footprint
17.1.11.5. Strategy Overview
17.1.11.5.1. Marketing Strategy
17.1.12. VirTech Bio
17.1.12.1. Overview
17.1.12.2. Product Portfolio
17.1.12.3. Profitability by Market Segments
17.1.12.4. Sales Footprint
17.1.12.5. Strategy Overview
17.1.12.5.1. Marketing Strategy
17.1.13. Vital Therapies
17.1.13.1. Overview
17.1.13.2. Product Portfolio
17.1.13.3. Profitability by Market Segments
17.1.13.4. Sales Footprint
17.1.13.5. Strategy Overview
17.1.13.5.1. Marketing Strategy
17.1.14. Hepa Tx
17.1.14.1. Overview
17.1.14.2. Product Portfolio
17.1.14.3. Profitability by Market Segments
17.1.14.4. Sales Footprint
17.1.14.5. Strategy Overview
17.1.14.5.1. Marketing Strategy
17.1.15. Humedics
17.1.15.1. Overview
17.1.15.2. Product Portfolio
17.1.15.3. Profitability by Market Segments
17.1.15.4. Sales Footprint
17.1.15.5. Strategy Overview
17.1.15.5.1. Marketing Strategy
Let us know your requirement to get
100% FREE customization
List of Tables
Table 1: Global Liver Transplantation Market Value (US$ Mn) Forecast by Region, 2016-2032
Table 2: Global Liver Transplantation Market Value (US$ Mn) Forecast by Treatment type, 2016-2032
Table 3: Global Liver Transplantation Market Value (US$ Mn) Forecast by End use, 2016-2032
Table 4: North America Liver Transplantation Market Value (US$ Mn) Forecast by Country, 2016-2032
Table 5: North America Liver Transplantation Market Value (US$ Mn) Forecast by Treatment type, 2016-2032
Table 6: North America Liver Transplantation Market Value (US$ Mn) Forecast by End use, 2016-2032
Table 7: Latin America Liver Transplantation Market Value (US$ Mn) Forecast by Country, 2016-2032
Table 8: Latin America Liver Transplantation Market Value (US$ Mn) Forecast by Treatment type, 2016-2032
Table 9: Latin America Liver Transplantation Market Value (US$ Mn) Forecast by End use, 2016-2032
Table 10: Europe Liver Transplantation Market Value (US$ Mn) Forecast by Country, 2016-2032
Table 11: Europe Liver Transplantation Market Value (US$ Mn) Forecast by Treatment type, 2016-2032
Table 12: Europe Liver Transplantation Market Value (US$ Mn) Forecast by End use, 2016-2032
Table 13: South Asia Liver Transplantation Market Value (US$ Mn) Forecast by Country, 2016-2032
Table 14: South Asia Liver Transplantation Market Value (US$ Mn) Forecast by Treatment type, 2016-2032
Table 15: South Asia Liver Transplantation Market Value (US$ Mn) Forecast by End use, 2016-2032
Table 16: East Asia Liver Transplantation Market Value (US$ Mn) Forecast by Country, 2016-2032
Table 17: East Asia Liver Transplantation Market Value (US$ Mn) Forecast by Treatment type, 2016-2032
Table 18: East Asia Liver Transplantation Market Value (US$ Mn) Forecast by End use, 2016-2032
Table 19: Oceania Liver Transplantation Market Value (US$ Mn) Forecast by Country, 2016-2032
Table 20: Oceania Liver Transplantation Market Value (US$ Mn) Forecast by Treatment type, 2016-2032
Table 21: Oceania Liver Transplantation Market Value (US$ Mn) Forecast by End use, 2016-2032
Table 22: MEA Liver Transplantation Market Value (US$ Mn) Forecast by Country, 2016-2032
Table 23: MEA Liver Transplantation Market Value (US$ Mn) Forecast by Treatment type, 2016-2032
Table 24: MEA Liver Transplantation Market Value (US$ Mn) Forecast by End use, 2016-2032
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystList of Charts
Figure 1: Global Liver Transplantation Market Value (US$ Mn) by Treatment type, 2022-2032
Figure 2: Global Liver Transplantation Market Value (US$ Mn) by End use, 2022-2032
Figure 3: Global Liver Transplantation Market Value (US$ Mn) by Region, 2022-2032
Figure 4: Global Liver Transplantation Market Value (US$ Mn) Analysis by Region, 2016-2032
Figure 5: Global Liver Transplantation Market Value Share (%) and BPS Analysis by Region, 2022-2032
Figure 6: Global Liver Transplantation Market Y-o-Y Growth (%) Projections by Region, 2022-2032
Figure 7: Global Liver Transplantation Market Value (US$ Mn) Analysis by Treatment type, 2016-2032
Figure 8: Global Liver Transplantation Market Value Share (%) and BPS Analysis by Treatment type, 2022-2032
Figure 9: Global Liver Transplantation Market Y-o-Y Growth (%) Projections by Treatment type, 2022-2032
Figure 10: Global Liver Transplantation Market Value (US$ Mn) Analysis by End use, 2016-2032
Figure 11: Global Liver Transplantation Market Value Share (%) and BPS Analysis by End use, 2022-2032
Figure 12: Global Liver Transplantation Market Y-o-Y Growth (%) Projections by End use, 2022-2032
Figure 13: Global Liver Transplantation Market Attractiveness by Treatment type, 2022-2032
Figure 14: Global Liver Transplantation Market Attractiveness by End use, 2022-2032
Figure 15: Global Liver Transplantation Market Attractiveness by Region, 2022-2032
Figure 16: North America Liver Transplantation Market Value (US$ Mn) by Treatment type, 2022-2032
Figure 17: North America Liver Transplantation Market Value (US$ Mn) by End use, 2022-2032
Figure 18: North America Liver Transplantation Market Value (US$ Mn) by Country, 2022-2032
Figure 19: North America Liver Transplantation Market Value (US$ Mn) Analysis by Country, 2016-2032
Figure 20: North America Liver Transplantation Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 21: North America Liver Transplantation Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 22: North America Liver Transplantation Market Value (US$ Mn) Analysis by Treatment type, 2016-2032
Figure 23: North America Liver Transplantation Market Value Share (%) and BPS Analysis by Treatment type, 2022-2032
Figure 24: North America Liver Transplantation Market Y-o-Y Growth (%) Projections by Treatment type, 2022-2032
Figure 25: North America Liver Transplantation Market Value (US$ Mn) Analysis by End use, 2016-2032
Figure 26: North America Liver Transplantation Market Value Share (%) and BPS Analysis by End use, 2022-2032
Figure 27: North America Liver Transplantation Market Y-o-Y Growth (%) Projections by End use, 2022-2032
Figure 28: North America Liver Transplantation Market Attractiveness by Treatment type, 2022-2032
Figure 29: North America Liver Transplantation Market Attractiveness by End use, 2022-2032
Figure 30: North America Liver Transplantation Market Attractiveness by Country, 2022-2032
Figure 31: Latin America Liver Transplantation Market Value (US$ Mn) by Treatment type, 2022-2032
Figure 32: Latin America Liver Transplantation Market Value (US$ Mn) by End use, 2022-2032
Figure 33: Latin America Liver Transplantation Market Value (US$ Mn) by Country, 2022-2032
Figure 34: Latin America Liver Transplantation Market Value (US$ Mn) Analysis by Country, 2016-2032
Figure 35: Latin America Liver Transplantation Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 36: Latin America Liver Transplantation Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 37: Latin America Liver Transplantation Market Value (US$ Mn) Analysis by Treatment type, 2016-2032
Figure 38: Latin America Liver Transplantation Market Value Share (%) and BPS Analysis by Treatment type, 2022-2032
Figure 39: Latin America Liver Transplantation Market Y-o-Y Growth (%) Projections by Treatment type, 2022-2032
Figure 40: Latin America Liver Transplantation Market Value (US$ Mn) Analysis by End use, 2016-2032
Figure 41: Latin America Liver Transplantation Market Value Share (%) and BPS Analysis by End use, 2022-2032
Figure 42: Latin America Liver Transplantation Market Y-o-Y Growth (%) Projections by End use, 2022-2032
Figure 43: Latin America Liver Transplantation Market Attractiveness by Treatment type, 2022-2032
Figure 44: Latin America Liver Transplantation Market Attractiveness by End use, 2022-2032
Figure 45: Latin America Liver Transplantation Market Attractiveness by Country, 2022-2032
Figure 46: Europe Liver Transplantation Market Value (US$ Mn) by Treatment type, 2022-2032
Figure 47: Europe Liver Transplantation Market Value (US$ Mn) by End use, 2022-2032
Figure 48: Europe Liver Transplantation Market Value (US$ Mn) by Country, 2022-2032
Figure 49: Europe Liver Transplantation Market Value (US$ Mn) Analysis by Country, 2016-2032
Figure 50: Europe Liver Transplantation Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 51: Europe Liver Transplantation Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 52: Europe Liver Transplantation Market Value (US$ Mn) Analysis by Treatment type, 2016-2032
Figure 53: Europe Liver Transplantation Market Value Share (%) and BPS Analysis by Treatment type, 2022-2032
Figure 54: Europe Liver Transplantation Market Y-o-Y Growth (%) Projections by Treatment type, 2022-2032
Figure 55: Europe Liver Transplantation Market Value (US$ Mn) Analysis by End use, 2016-2032
Figure 56: Europe Liver Transplantation Market Value Share (%) and BPS Analysis by End use, 2022-2032
Figure 57: Europe Liver Transplantation Market Y-o-Y Growth (%) Projections by End use, 2022-2032
Figure 58: Europe Liver Transplantation Market Attractiveness by Treatment type, 2022-2032
Figure 59: Europe Liver Transplantation Market Attractiveness by End use, 2022-2032
Figure 60: Europe Liver Transplantation Market Attractiveness by Country, 2022-2032
Figure 61: South Asia Liver Transplantation Market Value (US$ Mn) by Treatment type, 2022-2032
Figure 62: South Asia Liver Transplantation Market Value (US$ Mn) by End use, 2022-2032
Figure 63: South Asia Liver Transplantation Market Value (US$ Mn) by Country, 2022-2032
Figure 64: South Asia Liver Transplantation Market Value (US$ Mn) Analysis by Country, 2016-2032
Figure 65: South Asia Liver Transplantation Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 66: South Asia Liver Transplantation Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 67: South Asia Liver Transplantation Market Value (US$ Mn) Analysis by Treatment type, 2016-2032
Figure 68: South Asia Liver Transplantation Market Value Share (%) and BPS Analysis by Treatment type, 2022-2032
Figure 69: South Asia Liver Transplantation Market Y-o-Y Growth (%) Projections by Treatment type, 2022-2032
Figure 70: South Asia Liver Transplantation Market Value (US$ Mn) Analysis by End use, 2016-2032
Figure 71: South Asia Liver Transplantation Market Value Share (%) and BPS Analysis by End use, 2022-2032
Figure 72: South Asia Liver Transplantation Market Y-o-Y Growth (%) Projections by End use, 2022-2032
Figure 73: South Asia Liver Transplantation Market Attractiveness by Treatment type, 2022-2032
Figure 74: South Asia Liver Transplantation Market Attractiveness by End use, 2022-2032
Figure 75: South Asia Liver Transplantation Market Attractiveness by Country, 2022-2032
Figure 76: East Asia Liver Transplantation Market Value (US$ Mn) by Treatment type, 2022-2032
Figure 77: East Asia Liver Transplantation Market Value (US$ Mn) by End use, 2022-2032
Figure 78: East Asia Liver Transplantation Market Value (US$ Mn) by Country, 2022-2032
Figure 79: East Asia Liver Transplantation Market Value (US$ Mn) Analysis by Country, 2016-2032
Figure 80: East Asia Liver Transplantation Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 81: East Asia Liver Transplantation Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 82: East Asia Liver Transplantation Market Value (US$ Mn) Analysis by Treatment type, 2016-2032
Figure 83: East Asia Liver Transplantation Market Value Share (%) and BPS Analysis by Treatment type, 2022-2032
Figure 84: East Asia Liver Transplantation Market Y-o-Y Growth (%) Projections by Treatment type, 2022-2032
Figure 85: East Asia Liver Transplantation Market Value (US$ Mn) Analysis by End use, 2016-2032
Figure 86: East Asia Liver Transplantation Market Value Share (%) and BPS Analysis by End use, 2022-2032
Figure 87: East Asia Liver Transplantation Market Y-o-Y Growth (%) Projections by End use, 2022-2032
Figure 88: East Asia Liver Transplantation Market Attractiveness by Treatment type, 2022-2032
Figure 89: East Asia Liver Transplantation Market Attractiveness by End use, 2022-2032
Figure 90: East Asia Liver Transplantation Market Attractiveness by Country, 2022-2032
Figure 91: Oceania Liver Transplantation Market Value (US$ Mn) by Treatment type, 2022-2032
Figure 92: Oceania Liver Transplantation Market Value (US$ Mn) by End use, 2022-2032
Figure 93: Oceania Liver Transplantation Market Value (US$ Mn) by Country, 2022-2032
Figure 94: Oceania Liver Transplantation Market Value (US$ Mn) Analysis by Country, 2016-2032
Figure 95: Oceania Liver Transplantation Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 96: Oceania Liver Transplantation Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 97: Oceania Liver Transplantation Market Value (US$ Mn) Analysis by Treatment type, 2016-2032
Figure 98: Oceania Liver Transplantation Market Value Share (%) and BPS Analysis by Treatment type, 2022-2032
Figure 99: Oceania Liver Transplantation Market Y-o-Y Growth (%) Projections by Treatment type, 2022-2032
Figure 100: Oceania Liver Transplantation Market Value (US$ Mn) Analysis by End use, 2016-2032
Figure 101: Oceania Liver Transplantation Market Value Share (%) and BPS Analysis by End use, 2022-2032
Figure 102: Oceania Liver Transplantation Market Y-o-Y Growth (%) Projections by End use, 2022-2032
Figure 103: Oceania Liver Transplantation Market Attractiveness by Treatment type, 2022-2032
Figure 104: Oceania Liver Transplantation Market Attractiveness by End use, 2022-2032
Figure 105: Oceania Liver Transplantation Market Attractiveness by Country, 2022-2032
Figure 106: MEA Liver Transplantation Market Value (US$ Mn) by Treatment type, 2022-2032
Figure 107: MEA Liver Transplantation Market Value (US$ Mn) by End use, 2022-2032
Figure 108: MEA Liver Transplantation Market Value (US$ Mn) by Country, 2022-2032
Figure 109: MEA Liver Transplantation Market Value (US$ Mn) Analysis by Country, 2016-2032
Figure 110: MEA Liver Transplantation Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 111: MEA Liver Transplantation Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 112: MEA Liver Transplantation Market Value (US$ Mn) Analysis by Treatment type, 2016-2032
Figure 113: MEA Liver Transplantation Market Value Share (%) and BPS Analysis by Treatment type, 2022-2032
Figure 114: MEA Liver Transplantation Market Y-o-Y Growth (%) Projections by Treatment type, 2022-2032
Figure 115: MEA Liver Transplantation Market Value (US$ Mn) Analysis by End use, 2016-2032
Figure 116: MEA Liver Transplantation Market Value Share (%) and BPS Analysis by End use, 2022-2032
Figure 117: MEA Liver Transplantation Market Y-o-Y Growth (%) Projections by End use, 2022-2032
Figure 118: MEA Liver Transplantation Market Attractiveness by Treatment type, 2022-2032
Figure 119: MEA Liver Transplantation Market Attractiveness by End use, 2022-2032
Figure 120: MEA Liver Transplantation Market Attractiveness by Country, 2022-2032
Need specific information?
Request CustomizationExplore Healthcare Insights
View Reports
